Skip to main content

Segura Dávila, Karen

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Segura Dávila, Karen

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Iñigo Ojanguren Arranz

Iñigo Ojanguren Arranz

Main researcher
Pneumology
Read more
Ibai Los Arcos Bertiz

Ibai Los Arcos Bertiz

Main researcher
Infectious Diseases
Read more
Barbara Citoler Naval

Barbara Citoler Naval

Research technician
Psychiatry, Mental Health and Addictions
Read more
Breogan Rodriguez Acevedo

Breogan Rodriguez Acevedo

Senior researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.